This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
2g | $200 | Check With Us |
5g | $330 | Check With Us |
10g | $495 | Check With Us |
Cat #: V1115 CAS #: 2315-02-8 Purity ≥ 98%
Description: Oxymetazoline HCl (Rhinofrenol; Afrin; Ocuclear; Drixine; Nezeril; Sinerol; Hazol; Nafrine; Navasin), the hydrochloride salt of oxymetazoline, is an imidazole-based α1 and α2 adrenergic receptor agonist.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 296.84 |
---|---|
Molecular Formula | C16H24N2O.HCl |
CAS No. | 2315-02-8 |
Storage | -20℃ for 3 years in powder formr |
-80℃ for 2 years in solvent | |
Solubility In Vitro | DMSO: 59 mg/mL (198.7 mM)r |
Water: 59 mg/mL (198.7 mM)r | |
Ethanol: NA | |
Solubility In Vivo | Chemical Name: 6-tert-butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethylphenol hydrochloride InChi Key: BEEDODBODQVSIM-UHFFFAOYSA-N InChi Code: InChI=1S/C16H24N2O.ClH/c1-10-8-13(16(3,4)5)15(19)11(2)12(10)9-14-17-6-7-18-14;/h8,19H,6-7,9H2,1-5H3,(H,17,18);1H SMILES Code: OC1=C(C(C)(C)C)C=C(C)C(CC2=NCCN2)=C1C.[H]Cl |
Synonyms | Oxylazine; Rhinofrenol; Afrin; Ocuclear; Drixine; Nezeril; Sinerol; Hazol; Nafrine; Navasin; oxymeta zoline; Ocuclear; |
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 3.3688 mL | 16.8441 mL | 33.6882 mL | 67.3764 mL |
5mM | 0.6738 mL | 3.3688 mL | 6.7376 mL | 13.4753 mL |
10mM | 0.3369 mL | 1.6844 mL | 3.3688 mL | 6.7376 mL |
20mM | 0.1684 mL | 0.8422 mL | 1.6844 mL | 3.3688 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.